Genomictree Inc.
228760
Hisse Senetlerindeki Sıralama
#19170
Genomictree Inc. is a molecular diagnostics firm that harnesses biomarkers to... Genomictree Inc. is a molecular diagnostics firm that harnesses biomarkers to develop and market advanced detection tools for both oncological conditions and various infectious diseases. Its product line includes EarlyTect C, a screening solution for the early identification of colorectal cancer. For lung cancer, it offers EarlyTect L, which targets epigenetic markers in patients with pulmonary nodules, and for bladder cancer, EarlyTect B, designed to detect specific genetic and epigenetic markers in individuals with hematuria. The company also provides a range of companion diagnostics: AccuraTect-KRAS and AccuraTect-BRAF assist in colorectal cancer management, while AccuraTect-EGFR supports lung cancer treatment. In addition, Genomictree supplies AccuraDTect SARS-CoV-2 RT-qPCR kits for infectious disease testing, and offers its technologies to support various diagnostic test providers. Founded in 2000, the company is based in Daejeon, South Korea.
Hisse Fiyatı
$6.61
Piyasa Değeri
$162.26M
Değişim (1 gün)
1.06%
Değişim (1 yıl)
-50.87%
Ülke
KR
Ticaret Genomictree Inc. (228760)
Kategori
Healthcare
Piyasa Değeri Genomictree Inc.(228760)
Piyasa Değeri: $162.26M
October 2026 itibarıyla Genomictree Inc. şirketinin piyasa değeri $162.26M. Bu, verilerimize göre Genomictree Inc. şirketini dünyanın en değerli 19170th. şirketi yapar. Piyasa değeri, halka açık bir şirketin tedavüldeki hisse senetlerinin toplam piyasa değeri olup, bir şirketin değerini ölçmek için yaygın olarak kullanılır.
Genomictree Inc. piyasa değeri geçmişi (2017 - 2026)
En Popüler 5 stocks ile karşılaştırıldığında 228760
